🇺🇸 FDA
Patent

US 11963953

Deuterated compounds for restoring mutant p53 function

granted A61KA61K31/454

Quick answer

US patent 11963953 (Deuterated compounds for restoring mutant p53 function) held by PMV PHARMACEUTICALS, INC. expires Mon Apr 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PMV PHARMACEUTICALS, INC.
Grant date
Tue Apr 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
33
CPC classes
A61K, A61K31/454